Fundraising Fox
🦊/People
Sign in

Andreas Jurgeit

Investor

Partner at Gimv · Board director at Mediar Therapeutics · Director at Indi Molecular

Germany

Find your path to Andreas

184 people in our graph share verified history with Andreas — schools, employers, funds. One of them is your warm intro.

Cassidy BlundellunlockedAndreas: together at Mediar Therapeutics
Andreas: together at Mediar Therapeutics
Andreas: together at University of Zurich
Andreas: together at Gimv

About

Andreas Jurgeit joined Gimv's Health & Care team in 2021. He previously worked at Lundbeckfonden Emerge in Copenhagen and at Merck Ventures in Amsterdam, where he handled VC investments and company creation across Europe, the US, and Israel, and began his career at Redalpine Venture Partners in Zurich. He holds a PhD in Cell Biology/Virology from the University of Zurich and a master's degree in Molecular Biology from the University of Innsbruck.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthHealthtech

Board director at Mediar Therapeutics

Intro paths

→

In turn, Andreas can intro founders to Mediar Therapeutics's investors below.

Mediar Therapeutics's investors · 10

Agent CapitalWalthamAmplitude Venture CapitalMontreal · since 2026Longwood FundBoston · since 2026Mission BiocapitalSan Francisco · $500K checks · since 2025Novartis Venture FundBasel · $5M – $25M checks · since 2022Ono Venture Investment, Inc.South San FranciscoPfizer Venture Investments$5M – $20M checksPfizer VenturesShangBay Capital LLCPalo AltoSofinnova PartnersParis · $540K – $27M checks · since 2025

Director at Indi Molecular

Intro paths

→

In turn, Andreas can intro founders to Indi Molecular's investors below.

Indi Molecular's investors · 3

Asset Management CompanyMenlo Park · $500K – $2M checks · since 2017Legend CapitalBeijing · $2.9M – $156M checks · since 2017M VenturesLos Angeles · $10.8M checks · since 2017

Co-founders at Indi Molecular

JH
James HeathDirector

Experience

  1. GimvPartnercurrent2021 — present
  2. EXCIVA GmbHBoard Membercurrent2025 — present
  3. Mediar TherapeuticsBoard Membercurrent2022 — presentBoston, Massachusetts, United States
  4. ImmunOs Therapeutics AGBoard Membercurrent2022 — presentGreater Zurich Area
  5. Innosuisse - Schweizerische Agentur für InnovationsförderungCoach and Lecturercurrent2018 — presentZürich Area, Switzerland
  6. ETH Zurich / IFJ start-up essentialsLecturer2015 — 2023Zürich Area, Switzerland
  7. LundbeckfondenPartner, Lundbeckfonden Emerge2018 — 2021
  8. DNA ScriptBoard Member2017 — 2018
  9. Indi Molecular, Inc.Board Member2017 — 2018
  10. Merck VenturesDirector2016 — 2018
  11. Paul Scherrer Institut (PSI)Startup Creation2015 — 2016
  12. Redbiotec AGBusiness Development and Strategy2013 — 2015Zürich Area, Switzerland
  13. Redalpine Venture Partners AGInvestment Advisor2013 — 2014Zürich Area, Switzerland
  14. Redalpine Venture Partners AGInvestment Manager at Redalpine Venture Partners2012 — 2014Zürich Area, Switzerland
  15. Redalpine Venture Partners AGAssociate2011 — 2012Zürich Area, Switzerland
  16. University of ZurichPhD/PostDoc (Target Discovery, Antivirals)2006 — 2011
  17. Medizinische Universitaet InnsbruckResearch Assistant2005 — 2006
  18. Universität InnsbruckMasters in Molecular Biology / Biochemistry2001 — 2005Innsbruck

Skills & more

Venture Capital23Life Sciences16Drug Discovery5Research2Marketing Communications1Business Strategy10Market ResearchVirology9Cancer ResearchBiomarkersCell Biology10Image Analysis
+12 moreCell Based AssaysBiopharmaceuticalsBiochemistryInfectious DiseasesLifesciencesImmunologyCellCell CultureStrategic PlanningStrategyManagementMolecular Biology

From Andreas's professional profile.

Colleagues at Gimv

Christoph Kocher
Principal at Gimv
Ferdinand Becker
Principal at Gimv
Kalle Wanner
Principal at Gimv
Lars Timmer
Senior Principal at Gimv
Lisa Collet
Senior Principal at Gimv
Maja Markovic
Partner at Gimv
Maximilian von den Hoff
Principal at Gimv
Niklas Windmann
Principal at Gimv

Frequently asked questions

Who is Andreas Jurgeit?
Andreas Jurgeit joined Gimv's Health & Care team in 2021. He previously worked at Lundbeckfonden Emerge in Copenhagen and at Merck Ventures in Amsterdam, where he handled VC investments and company creation across Europe, the US, and Israel, and began his career at Redalpine Venture Partners in Zurich. He holds a PhD in Cell Biology/Virology from the University of Zurich and a master's degree in Molecular Biology from the University of Innsbruck.
Where does Andreas Jurgeit work?
Andreas Jurgeit is Partner at Gimv and Board director at Mediar Therapeutics.
What does Andreas Jurgeit invest in?
Andreas Jurgeit invests in Biotech, Digital Health, Healthtech.
Where did Andreas Jurgeit go to school?
Andreas Jurgeit studied at University of Zürich (PhD, Molecular Cell Biology & Virology); University of Innsbruck (Master of Science (MSc), Molecular Biology / Biochemistry); BRG Woergl.

Same school

Shared employers